These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8818575)

  • 1. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous measurement of nicotinic acid and its major metabolite, nicotinuric acid in urine using high-performance liquid chromatography: application of solid-liquid extraction.
    Iwaki M; Ogiso T; Hayashi H; Lin ET; Benet LZ
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):154-8. PubMed ID: 7866544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions.
    Ahlström C; Peletier LA; Jansson-Löfmark R; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):1-24. PubMed ID: 21046209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.
    Ahlström C; Kroon T; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):623-38. PubMed ID: 24114415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites.
    Menon RM; González MA; Adams MH; Tolbert DS; Leu JH; Cefali EA
    J Clin Pharmacol; 2007 Jun; 47(6):681-8. PubMed ID: 17463214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear pharmacokinetics of propafenone in rats and humans: application of a substrate depletion assay using hepatocytes for assessment of nonlinearity.
    Komura H; Iwaki M
    Drug Metab Dispos; 2005 Jun; 33(6):726-32. PubMed ID: 15743979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat.
    Bredberg U; Paalzow L
    Drug Metab Dispos; 1990; 18(3):338-43. PubMed ID: 1974196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplement.
    Wedge SR; Laohavinij S; Taylor GA; Boddy A; Calvert AH; Newell DR
    Clin Cancer Res; 1995 Dec; 1(12):1479-86. PubMed ID: 9815947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.
    Ahlström C; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):497-512. PubMed ID: 23824920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
    Satterwhite JH; Boudinot FD
    Drug Metab Dispos; 1991; 19(1):61-7. PubMed ID: 1673423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
    Bortolotti A; Jiritano L; Bonati M
    Drug Metab Dispos; 1985; 13(2):227-31. PubMed ID: 2859173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent kinetics of cilastatin in laboratory animals.
    Lin JH; Chen IW; Ulm EH
    Drug Metab Dispos; 1989; 17(4):426-32. PubMed ID: 2571484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
    Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
    Drug Metab Dispos; 1996 Aug; 24(8):911-21. PubMed ID: 8869828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dose-dependent fate of 1,4-dioxane in rats.
    Young JD; Braun WH; Gehring PJ
    J Environ Pathol Toxicol; 1978; 2(2):263-82. PubMed ID: 739213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of its demethylated metabolite on the pharmacokinetics of unchanged TAK-603, a new antirheumatic agent, in rats.
    Tagawa Y; Miwa K; Tsukuda R; Yoshimura Y; Tanayama S; Tanigawara Y
    Drug Metab Dispos; 1999 Apr; 27(4):495-501. PubMed ID: 10101145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.